Results 221 to 230 of about 505,494 (259)

Vascular Endothelial Growth Factor

Ceskoslovenska fysiologie, 2012
VEGF, vascular endothelial growth factor, is a substance firstly described in 1983 as a tumor-secreted protein which causes the development of ascitic fluid in case of abdominal tumors. Its influence on angiogenesis was ascertained by many studies. The strongest stimulus for its production is hypoxia, which leads to higher secretion of VEGF and new ...
R, Kaiser, P, Dubový, P, Haninec
  +5 more sources

Vascular Endothelial Growth Factor in Cervical Carcinoma

Obstetrics & Gynecology, 1999
To quantitate vascular endothelial growth factor of cervical carcinoma and elucidate its clinical correlation.Intratumoral protein levels of vascular endothelial growth factor were measured in 104 cervical cancer patients and in 30 cervical tissue specimens of benign gynecologic diseases as controls. The concentrations were correlated with clinical and
W F, Cheng, C A, Chen, C N, Lee, T M, Chen, F J, Hsieh, C Y, Hsieh   +5 more
openaire   +2 more sources

Vascular Endothelial Growth Factor and its Receptors

Retina, 1994
Vascular endothelial growth factor (VEGF) is a highly specific mitogen for vascular endothelial cells and an angiogenic factor that is structurally related to platelet derived growth factor (PDGF). It is also known as the vascular permeability factor (VPF) because it efficiently potentiates the permeabilization of blood vessels. Five types of VEGF mRNA
G, Neufeld, S, Tessler, H, Gitay-Goren, T, Cohen, B Z, Levi   +4 more
openaire   +2 more sources

Platelet-derived endothelial cell growth factor

Progress in Growth Factor Research, 1991
AbstractPlatelet‐derived endothelial cell growth factor (PD‐ECGF) is a 45kDa single chain polypeptide which stimulates endothelial cell growth and chemotaxis in vitro and angiogenesis in vivo. Analysis of a full length PD‐ECGF cDNA revealed an open reading frame coding for 482 amino acids without homology to other known proteins. No signal sequence was
K, Miyazono, K, Usuki, C H, Heldin
openaire   +3 more sources

Vascular Endothelial Growth Factor

2003
The striking structural and anatomical parallels between the vasculature and the nervous system is reflected by the fact that these two organ systems appear to use related mechanisms during their development. Thus, it is not surprising that an increasing number of vascular biologists and researchers in the neuroscience field are fascinated by molecules
openaire   +2 more sources

Vascular endothelial growth factor

Ophthalmology, 2007
Vascular endothelial growth factor (VEGF) signalling is a key stimulant of tumour neovascular growth, survival and capillary permeability, which are critical to solid tumour progression. The intracellular signalling responses that induce an angiogenic phenotype are dependent upon VEGF binding to specific transmembrane receptors on the endothelium and ...
Neil Swanson, Anthony Gershlick
  +4 more sources

Effects of Finasteride on Vascular Endothelial Growth Factor

Scandinavian Journal of Urology and Nephrology, 2002
Finasteride has been shown to reduce prostate bleeding in patients with benign prostatic hyperplasia (BPH). The mechanisms behind this are not known, but it has been suggested that finasteride reduces bleeding by inhibiting angiogenesis in the prostate. Studies in animals have shown that castration rapidly induces involution of the prostate vasculature,
Häggström, S., Tørring, Niels, Møller, K., Jensen, E., Lund, L., Nielsen, J.E., Bergh, A., Damber, J.-E.   +7 more
openaire   +3 more sources

Role of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptors in Vascular Development

1999
Distinct cellular processes mediate blood-vessel formation during embryogenesis (Beck and D’Amore 1997; Carmeliet and Collen 1998a; Folkman and D’Amore 1996; Noden 1989; Risau 1997; Wilting and Christ 1996) (Fig. 1). Initially, mesodermal cells differentiate in situ into early haemangioblasts and form cellular aggregates (blood islands), in which the ...
P, Carmeliet, D, Collen
openaire   +2 more sources

Antivascular Endothelial Growth Factor in Diabetic Retinopathy

2010
Diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) represent the most common causes of vision loss in patients affected by diabetes mellitus. Diabetic retinopathy (DR) needs special attention because of its high public health impact and impact on quality of life of patients.
Iacono P, Battaglia Parodi M, Bandello F.   +2 more
openaire   +3 more sources

Antivascular Endothelial Growth Factor in Hereditary Dystrophies

2010
Choroidal neovascularization can rarely complicate the course of a number of chorioretinal hereditary dystrophies leading to an even further impaired vision function. In recent years, several case reports and case series have shown that intravitreal injections of antivascular endothelial growth factor drugs can be effective in treating subfoveal ...
Battaglia Parodi M, Iacono P, Bandello F.   +2 more
openaire   +2 more sources